Walgreens Boots Alliance, Inc. $WBA Shares Sold by Wellington Management Group LLP

Key Points

• Wellington Management Group LLP has reduced its stake in Walgreens Boots Alliance by 33.4%, selling 68,451 shares and decreasing its holdings to 136,528 shares valued at approximately $1.525 million.
• Walgreens Boots Alliance reported $0.38 earnings per share for the quarter, exceeding analyst estimates, while its quarterly revenue increased by 7.2% year-over-year to reach $38.99 billion.
• The current consensus rating for Walgreens Boots Alliance shares is "Reduce", with a target price set at $10.15, reflecting a mixed outlook from analysts.

Wellington Management Group LLP cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 33.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,528 shares of the pharmacy operator's stock after selling 68,451 shares during the quarter. Wellington Management Group LLP's holdings in Walgreens Boots Alliance were worth $1,525,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Colonial Trust Co SC grew its stake in shares of Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,297 shares during the period. Sentry Investment Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $27,000. Curat Global LLC purchased a new stake in Walgreens Boots Alliance during the first quarter worth about $27,000. Federated Hermes Inc. grew its position in Walgreens Boots Alliance by 135.8% during the first quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock worth $35,000 after buying an additional 1,815 shares during the period. Finally, N.E.W. Advisory Services LLC purchased a new position in Walgreens Boots Alliance in the first quarter valued at about $43,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock remained flat at $11.98 during mid-day trading on Thursday. The firm has a market capitalization of $10.37 billion, a price-to-earnings ratio of -1.64, a price-to-earnings-growth ratio of 1.42 and a beta of 0.80. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $13.25. The company's 50-day simple moving average is $11.73 and its two-hundred day simple moving average is $11.29.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The firm had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.63 earnings per share. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen assumed coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating on the stock. Finally, Morgan Stanley reiterated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of "Reduce" and an average price target of $10.15.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.